CHEN Xinyi's experience in differentiating and treating malignant lymphoma by stages based on “turbidity-toxicity disease mechanism theory”

CHEN Yuecan; CHEN Xinyi; LANG Haiyan

doi:10.16025/j.1674-1307.2024.10.002

您当前的位置：

首页 >

文章列表页 >

CHEN Xinyi's experience in differentiating and treating malignant lymphoma by stages based on “turbidity-toxicity disease mechanism theory”

更新时间：2024-11-26

- CHEN Xinyi's experience in differentiating and treating malignant lymphoma by stages based on “turbidity-toxicity disease mechanism theory”
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 10, Pages: 1088-1091(2024)
- 作者机构：
  
  北京中医药大学东直门医院血液科，北京 100700
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.10.002
  CLC：
- Published：25 October 2024，
  
  Received：14 May 2024，
- 稿件说明：
移动端阅览
陈玥灿，陈信义，郎海燕.陈信义基于“浊毒病机论”分期辨治恶性淋巴瘤经验撷要［J］.北京中医药，2024，43（10）：1088-1091.

CHEN Yuecan,CHEN Xinyi,LANG Haiyan.CHEN Xinyi's experience in differentiating and treating malignant lymphoma by stages based on “turbidity-toxicity disease mechanism theory”[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(10):1088-1091.
陈玥灿，陈信义，郎海燕.陈信义基于“浊毒病机论”分期辨治恶性淋巴瘤经验撷要［J］.北京中医药，2024，43（10）：1088-1091. DOI： 10.16025/j.1674-1307.2024.10.002.

CHEN Yuecan,CHEN Xinyi,LANG Haiyan.CHEN Xinyi's experience in differentiating and treating malignant lymphoma by stages based on “turbidity-toxicity disease mechanism theory”[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(10):1088-1091. DOI： 10.16025/j.1674-1307.2024.10.002.

摘要

恶性淋巴瘤是一种高度异质性的血液系统恶性肿瘤，其从无形至有形、局部至全身的病理过程与“浊毒”弥漫、胶着、凝结的病理特性相关。陈信义教授基于多年临床经验认为，浊毒始终贯穿恶性淋巴瘤发生与发展的全过程，并倡导以“化浊解毒”为基本治疗原则，分期辨证、对症治疗。在治疗过程中，注重把握正邪消长变化，密切关注证候演变规律，重点强调辨证施治。结合恶性淋巴瘤的现代医学分期组方遣药：Ⅰ期应疏肝健脾、化浊解毒，方选逍遥散加减；Ⅱ期当软坚散结、化浊解毒、行气活血，方选消瘰丸合半夏藿香汤加减；Ⅲ期宜扶正祛邪、泄浊化瘀，方选八珍汤合泄化浊瘀汤加减；Ⅳ期拟益气补血、调理阴阳，方选人参养荣汤加减。

Abstract

关键词

陈信义恶性淋巴瘤浊毒病机论化浊解毒

Keywords

references

蓝海,侯丽,郎海燕,等.常见血液病的中医分类与命名[J].中医杂志,2019,60(9):750-753，778.

徐伟超,李佃贵,刘建平,等.浊毒理论创新中医病因病机学[J].中国中西医结合杂志,2019,39(8):913-915.

赵见文,田军彪,高利.基于“虚损-浊毒”论治重症肌无力初探[J].北京中医药,2023,42(4):422-425.

王少锋,李佳欣,郝彦伟,等.浊毒理论之考析与述评[J].辽宁中医杂志,2023,50(10):63-65.

李广森,王冰,樊茂蓉,等.基于“痰毒”理论探讨支气管扩张症的全程诊治[J].北京中医药,2023,42(8):831-834.

SIEGEL RL,GIAQUINTO AN,JEMAL A.Cancer statistics,2024[J].CA,2024,74(1):12-49.

中华人民共和国国家卫生健康委员会.淋巴瘤诊疗指南（2022年版）[J].中国肿瘤临床与康复,2023,30(3):135-158.

WANG L, QIN W, HUO YJ, et al. Advances in targeted therapy for malignant lymphoma[J]. STTT, 2020,5(1):15.

SCHMITZ R, WRIGHT GW, HUANG DW, et al. Genetics and pathogenesis of diffuse large B-Cell lymphoma[J]. NEJM, 2018,378(15):1396-1407.

中国抗癌协会淋巴瘤专业委员会,中国医师协会肿瘤医师分会,中国医疗保健国际交流促进会肿瘤内科分会.中国淋巴瘤治疗指南(2021年版)[J].中华肿瘤杂志,2021,43(7):707-735.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical status and research hotspots in the treatment of malignant lymphoma with traditional Chinese medicine

CHEN Xin-yi's experience in treating biphenotypic acute leukemia with traditional Chinese medicine

Related Author

LANG Haiyan

CHEN Yuecan

CHEN Xinyi

YAN Xiang

DING Hao

HUANG Zi-ming

ZHAO Qian

ZHANG Ya-yue

Related Institution

北京中医药大学东直门医院血液肿瘤科

山西省中医院血液科

⁰